Suchergebnisse - "Hernandez, Rosmely"

PubPharm (16)

1

Base-editing mutagenesis maps alleles to tune human T cell functions

enthalten in: Nature | 2024

von Schmidt, R. | Ward, C. | Dajani, R. | +17

2

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells

enthalten in: Journal for immunotherapy of cancer | 2023

von LaPorte, K. | Hernandez, R. | Santos Savio, A. | +1

3

Engineering IL-2 for immunotherapy of autoimmunity and cancer

enthalten in: Nature reviews. Immunology | 2022

von Hernandez, R. | Põder, J. | LaPorte, K. | +1

4

Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity

enthalten in: Frontiers in oncology | 2022

von Hernandez, R. | Malek, T.

5

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2021

von Hernandez, R. | LaPorte, K. | Hsiung, S. | +2

6

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Hernandez, R. | Toomer, K. | Põder, J. | +3

7

Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells

enthalten in: ImmunoHorizons | 2020

von Hsiung, S. | Moro, A. | Ban, Y. | +4

8

Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms

enthalten in: Diabetes | 2020

von Ward, N. | Lui, J. | Hernandez, R. | +8

9

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive $ CD8^{+} $ T cells to enhance antitumor immunity

enthalten in: Cancer immunology immunotherapy | 2020

von Hernandez, R. | Toomer, K. | Põder, J. | +3

10

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive $ CD8^{+} $ T cells to enhance antitumor immunity

enthalten in: Cancer immunology immunotherapy | 2020

von Hernandez, R. | Toomer, K. | Põder, J. | +3